Pharmaceutical Technology-07-02-2007

Pharmaceutical Technology

Injectable Administration Systems

July 02, 2007

Articles

31

7

During the past 30 years, manufacturers developed sophisticated packaging and delivery systems to support the requirements of traditional and complex biologics, including quality and cleanliness. This article discusses the evolution of packaging and delivery systems for injectable administration systems as the pharmaceutical and biotechnology industry evolved during the past 30 years. It also explores the future of packaging and delivery systems as technology and drug development advance.

A Perspective on Computer Validation

July 02, 2007

Articles

31

7

This article provides a historical review of computer validation in the pharmaceutical industry within the last three decades, evolving from the early years' initial concept and approach to today's current practices. Also included is how the regulations and industry have progressed in addressing the topic of computer validation.

Statistical Implications of the CGMPs: A 30-Year Retrospective

July 02, 2007

Articles

31

7

This article looks at the current good manufacturing practice regulations from a statistical perspective while addressing their requirements and implications and inviting the industry to assess its past performance in meeting the regulations.

Innovations Enable Packaging to Play Many Roles

July 02, 2007

Articles

31

7

Drug packaging performs functions such as ensuring patient well-being, providing information, preventing tampering, blocking counterfeiting, and improving compliance. Since 1977, packaging innovations have occurred in four major categories. The author provides an overview of major packaging improvements that have emerged in the past 30 years.

The Evolution of FDA's Role in Ensuring Product Quality

July 02, 2007

Articles

31

7

The quality of a drug product is an essential element of drug safety and efficacy. With a statutory mission to provide safe and effective medications to the public, the US Food and Drug Administration has always focused on drug quality. The authors summarize the history of FDA's role in ensuring product quality and its role in shaping risk-based approaches to this goal.

A New Manufacturing Framework

July 02, 2007

Articles

31

7

As a well-known and well-respected researcher, director, and speaker Fernando Muzzio shares his insights into the significant steps that have led to the "unprecedented" manufacturing industry of today.

Contaminated LVPs and the Origins of Validation

July 02, 2007

Articles

31

7

Fundamental validation skills related to heating, ventilation, and air conditioning must be thoroughly understood. Knowing the early history and development of validation is essential to understand the current set of regulations and standards governing the industry. This article reviews the history and outcome of contamination in large-volume parenteral drug products and discusses the qualification requirements of modern HVAC systems.

Innovations Abound

July 02, 2007

Viewpoint

31

7

Here's a look at some of the most interesting and thematic responses you-our readers-provided for Pharmaceutical Technology's anniversary survey of industry advances and directions.

To Lead, We Must Act Now

July 02, 2007

This Time Around

31

7

While recapping the past 30 years' innovations in pharmaceutical technology, it's also important to start preparing for the next 30 years. But staying ahead of the curve will be challenging.

A Look at 30 Years of Change in Pharmaceutical Automation

July 02, 2007

Articles

31

7

Automation took hold gradually in the life-science industry. Its adoption brought the industry innovations and improved efficiency. Recent years witnessed the emergence of batch-automation systems and the development of standards for automation. The authors discuss the major changes automation brought to the industry and examine the rapid pace of technological development.

Pharma Capsules

July 02, 2007

Pharma Capsules

31

7

Bioanalytical Systems (West Lafayette, IN) extended the employment contract of its president and CEO, Richard M. Shepperd, through December 31, 2009. Shepperd has served as interim president and CEO since October 2006.

Charting Process Improvement in Sterile Product Manufacturing

July 02, 2007

Articles

31

7

Sterile product manufacturing and related testing have evolved significantly during the last 30 years. From requirements for acceptance criteria for media-fill tests, to developing validated approaches for moist-heat sterilization, to the introduction of formalized sterility-testing practices, the pharmaceutical industry has made significant advances in testing and in key technology such as isolators, prefilled syringes, automation, and robotics. The author outlines the key regulatory and technical changes to sterile product manufacturing and takes a visionary look for the next era of sterile manufacturing marked by a greater emphasis on risk analysis.

Changes in Pharmaceutical Formulations and Drug Delivery Systems

July 02, 2007

31

7

The author reviews advancements in formulation that Pharmaceutical Technology has chronicled during the past 30 years. During this time, many novel solutions were investigated and finally became common and accepted techniques. The author also looks ahead to future developments in formulation and drug delivery methods.

Three Decades of Drug Regulation and Legislation

July 02, 2007

Articles

31

7

The US Food and Drug Administration has pursued many new initiatives since 1977. The agency began accepting abbreviated applications for generic versions of drugs, collected user fees to support drug review, launched the Critical Path Initiative to encourage innovation, and worked to harmonize its regulatory standards with those of Europe and Japan. New challenges such as AIDS and bioterrorism have affected regulatory policy in recent years. The author reviews FDA's changes in policy and philosophy during the past 30 years.

In The Field

July 02, 2007

In the Field

31

7

Trenton, NJ (May 18)-Pharmaceutical and medical technology companies in New Jersey have found a striking disparity between six high-demand occupations and the number of qualified workers to fill those positions, according to a report issued by the HealthCare Institute of New Jersey (HINJ). Modest job growth in this field is expected for the next four years, states the report.